Free Trial

Coeptis Therapeutics (COEP) SEC Filings & 10K Form

Coeptis Therapeutics logo
$0.14 0.00 (-2.08%)
(As of 12/20/2024 05:45 PM ET)

Recent Coeptis Therapeutics SEC Filings

DateFilerForm TypeView
12/20/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
11/22/2024
3:45 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
11/06/2024
3:40 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:30 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
7:00 AM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:01 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
08/16/2024
3:02 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
08/15/2024
7:16 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q/A
08/15/2024
7:17 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-K/A
08/15/2024
7:18 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q/A
08/15/2024
7:19 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
4:25 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
4:26 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form NT 10-Q
06/27/2024
2:04 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/26/2024
5:30 AM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
03/26/2024
5:30 AM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
03/25/2024
4:12 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q/A
03/25/2024
4:22 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q/A
03/25/2024
4:25 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-Q/A
03/25/2024
4:04 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
4:08 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 10-K/A
02/14/2024
2:32 PM
ARMISTICE CAPITAL, LLC (Filed by)
Coeptis Therapeutics Holdings, Inc. (Subject)
Coeptis Therapeutics Holdings, Inc. (Subject)
Coeptis Therapeutics (Subject)
Coeptis Therapeutics Holdings, Inc. (Subject)
Form SC 13G
02/05/2024
4:15 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
02/05/2024
4:17 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 424B3
02/01/2024
4:28 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
7:14 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
DeSilva Tara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
11:27 AM
Coeptis Therapeutics Holdings, Inc. (Subject)
Coeptis Therapeutics Holdings, Inc. (Subject)
Coeptis Therapeutics (Subject)
Coeptis Therapeutics Holdings, Inc. (Subject)
Geller Avi (Filed by)
Form SCHEDULE 13G
01/09/2024
4:30 PM
Cochran Christopher P. (Reporting)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:30 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Mehalick David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:31 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Salkind Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:32 PM
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Coeptis Therapeutics (Issuer)
Coeptis Therapeutics Holdings, Inc. (Issuer)
Yerace Daniel Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:01 PM
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Coeptis Therapeutics (Filer)
Coeptis Therapeutics Holdings, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COEP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners